Effect of WalkingTall with smart socks on gait stability in people with Parkinson's disease

Not Applicable

• Conditions: Parkinson's disease; Mobility impairment; Neurological - Parkinson's disease; Physical Medicine / Rehabilitation - Physiotherapy

• Registration Number: ACTRN12619001272189
• Lead Sponsor: Dr Matthew Brodie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-09-16
• Last Update Posted: 30 September 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Diagnosed with Parkinson’s disease;
Being stable on anti-Parkinsonian medications for >= 1 month;
Living independently in the community or retirement village;
Able to communicate in English language;

Exclusion Criteria

Inability to stand or walk 30m without assistance;
Diagnosis of other neurological and/or significant cognitive impairments (a Pfeiffer Short Portable Mental Status Questionnaire score <5);
Medical conditions which would preclude physical assessments or exercise training using smart socks (e.g. peripheral nephropathy causing inability to perceive external stimulus). Insufficient cognitive or physical capacity to comply with the intervention safely in an unsupervised environment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall effect of the intervention on gait stability (step-time variability [ms] assessed by from the middle 18 meters of a 22 meter walk [Henderson et al. 2016]). Change in step time variability between baseline without simulation and followup with smart sock stimulation. Both assessments are on medication. [Baseline (week 0) without socks and followup (week 3) with socks]